What Advanced Life Sciences Holdings does

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company that has historically been positioned around the discovery, development, and commercialization of drugs. The entity traces back to 1998 and previously traded on NASDAQ under the ticker ADLS before being delisted; it is now headquartered in Woodridge, Illinois, with a reported headcount of 1–10 employees. The current corporate website at advancedlifesciences.com is a placeholder "Launching Soon" page with a generic contact form and email sign-up, indicating the business is in a pre-commercial build-out phase rather than an active operating state.

There is no disclosed information on products, pipeline assets, indications, modalities, technology platforms, partnerships, management, funding, or revenue in the available data. As a result, the company description is necessarily limited to its stated category (biopharmaceutical drug development and commercialization), its prior public-market status, its small current scale, and the pre-launch posture conveyed by its web presence. No pricing, go-to-market, customer segment, or revenue model detail can be evidenced from the source material.

Name

Advanced Life Sciences Holdings

Website

https://advancedlifesciences.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Advanced Life Sciences Holdings is a small biopharmaceutical company focused on drug discovery, development, and commercialization. Founded in 1998 and based in Woodridge, Illinois, it operates a pre-launch website under its prior NASDAQ:ADLS brand with no disclosed products or revenue.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Drug Development

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Biopharmaceutical development
• Drug discovery
• Drug commercialization
• Therapeutic research
• Pharmaceutical holdings

Headquarters

HQ city

Woodridge

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations

Core offering

Advanced Life Sciences Holdings, Inc. is described as a biopharmaceutical company focused on the discovery, development, and commercialization of drugs. The company's current public-facing website is a 'Launching Soon' placeholder page with no specific products, pipeline assets, or services listed.

Product overview

No product or service information is available. The company website displays only a 'Launching Soon' placeholder page with no product descriptions, offerings, or portfolio details.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• Melinta Therapeutics: Biopharmaceutical company developing antibiotics for serious infections. Directly comparable as a small-cap anti-infective drug developer with similar therapeutic area and commercialization-stage ambitions to Advanced Life Sciences.
• Cidara Therapeutics: Clinical-stage biopharmaceutical company developing anti-infective therapeutics. Comparable as a small-cap drug discovery and development company in the anti-infective space with similar commercialization-stage positioning.
• Entasis Therapeutics: Clinical-stage biopharmaceutical company developing differentiated antibacterial products. Comparable anti-infective focus and small-cap biopharma profile aligned with Advanced Life Sciences' historical therapeutic area.
• Nabriva Therapeutics: Biopharmaceutical company focused on developing and commercializing novel anti-infective agents. Highly comparable to Advanced Life Sciences given overlapping anti-infective/antibiotic therapeutic focus and similar small-cap, development-stage profile.
• VenatoRx Pharmaceuticals: Private biopharmaceutical company developing novel anti-infective therapies to address drug-resistant bacterial infections. Comparable as a small-cap biopharma focused on anti-infective drug discovery and development.
• Iterum Therapeutics: Clinical-stage biopharmaceutical company developing anti-infective drugs. Comparable as a small-cap, development-stage drug company focused on therapeutic commercialization, similar in profile to Advanced Life Sciences' historical anti-infective orientation.
• Paratek Pharmaceuticals: Small-cap U.S. biopharmaceutical company developing and commercializing therapeutic drugs, including anti-infectives. Directly comparable to Advanced Life Sciences' stated focus on drug discovery, development and commercialization at a similar small-cap scale.
• Tetraphase Biosciences: Biopharmaceutical company focused on developing tetracycline-derived antibiotics. Comparable as a small-cap anti-infective drug developer with similar discovery-to-commercialization trajectory to Advanced Life Sciences.

Others

• Achaogen: Former biopharmaceutical company that developed and commercialized antibiotics, now serves as a cautionary historical peer for small-cap anti-infective drug developers like Advanced Life Sciences given the well-documented capital and commercialization challenges in this therapeutic area.

Broad incumbents

• Seres Therapeutics: Clinical-stage biopharmaceutical company developing microbiome therapeutics. Comparable as a U.S.-based, small/mid-cap biopharma with a discovery, development and commercialization mandate in therapeutic drug development.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights3 records

Customer concentration

• Facebookfacebook.com/lifesciadvtech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Life Sciences Holdings